Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
Berger Dietmar
Chief Medical Officer·Direct
Exercise · Dispose
Restricted Stock UnitDerivative
Shares-533
Price-
Total Value$0
Shares Owned After46.93K
Transaction DateJun 10, 2026
Footnotes ▸
Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. | Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. | The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested. | The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested.
Berger Dietmar
Chief Medical Officer·Direct
Tax W/H · Dispose
Common Stock
Shares-263
Price$121.48
Total Value$31.9K
Shares Owned After19.25K
Transaction DateJun 10, 2026
Post-Transaction Holdings
Berger Dietmar
Security
Shares
Change
Common Stock
19.52K
+270 (1.40%)
Restricted Stock Unit
46.93K
-533 (-1.12%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-06-10
10b5-1 Pre-arranged Plan: No
--- Issuer ---
Name: GILEAD SCIENCES, INC. (GILD)
CIK: 0000882095
--- Reporting Owner ---
Name: Berger Dietmar
CIK: 0001739515
Role: Officer (Chief Medical Officer)
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock
Date: 2026-06-10 | Code: M (Exercise of derivative)
Shares: +533
Shares Owned After: 19,515 | Ownership: D (Direct)
Footnotes:
[F1] Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
[Transaction #2]
Security: Common Stock
Date: 2026-06-10 | Code: F (Payment of exercise/tax)
Shares: -263 | Price: $121.48
Total Value: $31,949.24
Shares Owned After: 19,252 | Ownership: D (Direct)
--- Derivative Transactions ---
[Transaction #1]
Security: Restricted Stock Unit
Date: 2026-06-10 | Code: M (Exercise of derivative)
Shares: -533
Shares Owned After: 46,928 | Ownership: D (Direct)
Footnotes:
[F1] Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
[F1] Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
[F2] The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested.
[F2] The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested.
--- Footnotes (Complete Index) ---
F1: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2: The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested.
--- Signature ---
/s/ /s/ Amy Kim by Power of Attorney for Dietmar Berger (2026-06-11)
